Our website uses cookies to improve and personalise your experience and to display advertisements(if any). Our website may also include third-party cookies like Google Adsense, Google Analytics, and Youtube. By using the website, you consent to the use of cookies. We have updated our Privacy Policy. Please click on the button to check our Privacy Policy.

COVID: new antibody treatment could offer up to 18 months’ protection against severe disease

COVID: new antibody treatment could offer up to 18 months’ protection against severe disease

A new treatment could soon help protect people from developing severe COVID. AstraZeneca has just released results from a phase 3 clinical trial – the final stage of testing before a drug is authorised – that suggest its new COVID treatment, AZD7442, is effective at reducing severe disease or death in non-hospitalised COVID patients. REBECCA AICHELER, Senior Lecturer in Immunology, Cardiff Metropolitan University The treatment contains antibodies, which are usually produced naturally in response to a COVID infection or vaccination. They work by recognising specific parts of SARS-CoV-2 – the virus that causes COVID – and either attack these directly…
Read More